Related Experiment Video
Updated: Jul 16, 2026

A Functional Assay for Gap Junctional Examination; Electroporation of Adherent Cells on Indium-Tin Oxide
Published on: October 18, 2014
Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression
Leonard Girnita1, Sudha K Shenoy, Bita Sehat
1Department of Oncology and Pathology, Division of Cellular and Molecular Tumor Pathology, CCK, R8:04, Karolinska Hospital, SE-171 76 Stockholm, Sweden, and Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. Leonard.Girnita@ki.se
Abstract:
Beta-arrestin1, which regulates many aspects of seven transmembrane receptor (7TMR) biology, has also been shown to serve as an adaptor, which brings Mdm2, an E3 ubiquitin ligase to the insulin-like growth factor-1 receptor (IGF-1R), leading to its proteasome-dependent destruction. Here we demonstrate that IGF-1R stimulation also leads to ubiquitination of beta-arrestin1, which regulates vesicular trafficking and activation of ERK1/2. This beta-arrestin1-dependent ERK activity can occur even when the classical tyrosine kinase signaling is impaired. siRNA-mediated suppression of beta-arrestin1 in human melanoma cells ablates IGF-1-stimulated ERK and prolongs the G1 phase of the cell cycle. These data suggest that beta-arrestin-dependent ERK signaling by the IGF-1R regulates cell cycle progression and may thus be an important regulator of the growth of normal and malignant cells.
Insights
Beta-arrestin1 links insulin-like growth factor-1 receptor (IGF-1R) to Mdm2 for degradation. New findings show IGF-1R stimulation also ubiquitinates beta-arrestin1, activating ERK signaling and regulating cell cycle progression.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Beta-arrestin1 acts as an adaptor protein in seven transmembrane receptor (7TMR) signaling.
- Beta-arrestin1 facilitates the interaction between Mdm2 (an E3 ubiquitin ligase) and the insulin-like growth factor-1 receptor (IGF-1R), targeting IGF-1R for proteasomal degradation.
Purpose of the Study:
- To investigate the role of beta-arrestin1 ubiquitination in insulin-like growth factor-1 receptor (IGF-1R) signaling.
- To elucidate the downstream signaling pathways regulated by beta-arrestin1 in response to IGF-1R stimulation.
- To determine the impact of beta-arrestin1-dependent signaling on cell cycle progression.
Main Methods:
- Utilized human melanoma cells for experimental studies.
- Employed siRNA-mediated suppression to reduce beta-arrestin1 levels.
- Investigated the ubiquitination status of beta-arrestin1 following IGF-1R stimulation.
- Assessed the activation of ERK1/2 signaling pathway.
- Monitored cell cycle progression (G1 phase).
Main Results:
- IGF-1R stimulation induces ubiquitination of beta-arrestin1.
- Beta-arrestin1 ubiquitination is linked to regulation of vesicular trafficking and ERK1/2 activation.
- Beta-arrestin1-dependent ERK activity can be independent of classical tyrosine kinase signaling.
- siRNA-mediated suppression of beta-arrestin1 inhibited IGF-1-stimulated ERK activation and prolonged the G1 phase of the cell cycle in human melanoma cells.
Conclusions:
- Beta-arrestin1 plays a crucial role in IGF-1R signaling beyond its role in receptor degradation.
- Beta-arrestin1-dependent ERK signaling pathway is critical for regulating cell cycle progression.
- This pathway represents a potential target for controlling the growth of normal and malignant cells.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Negative Regulator Molecules
MAPK Signaling Cascades
Regulation of the Unfolded Protein Response
